Titre:
  • A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis.
Auteur:Body, Jean-Jacques; Gaich, Gregory A; Scheele, Wim H; Kulkarni, Pandurang M; Miller, Paul; Peretz, Anne; Dore, Robin K; Correa-Rotter, Ricardo; Papaioannou, Alexandra; Cumming, David C; Hodsman, Anthony B
Informations sur la publication:The Journal of clinical endocrinology and metabolism, 87, 10, page (4528-4535)
Statut de publication:Publié, 2002-10
Sujet CREF:Cancérologie
MeSH keywords:Adult
Aged
Aged, 80 and over
Alendronate -- therapeutic use
Alkaline Phosphatase -- blood
Biological Markers
Body Height -- drug effects
Bone Density -- drug effects
Bone Remodeling -- drug effects
Bone Resorption -- prevention & control
Bone and Bones -- enzymology -- injuries
Calcitriol -- blood
Collagen -- urine
Collagen Type I
Double-Blind Method
Female
Fractures, Bone -- prevention & control
Humans
Middle Aged
Osteoporosis, Postmenopausal -- drug therapy
Peptides -- urine
Teriparatide -- therapeutic use
Note générale:Clinical Trial
Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0021-972X
info:doi/10.1210/jc.2002-020334
info:scp/18644374464
info:pmid/12364430